4.4 (0.26%)
4.95 (0.29%) 1.05 pm | 21 Dec 2011 | Source: CNBC-TV18
Ipca Labs and Lupin are top picks in pharma space, says Rajesh Agarwal, Head of Research, Eastern Financiers....
8.35 am | 07 Dec 2011 | Source: CNBC-TV18
On CNBC-TV18's show Super Six, market gurus Manas Jaiswal, Technical Analyst, manasjaiswal.com, Vishal Kshatriya, Sr. Derivative and Technical Analyst...
2.33 pm | 05 Dec 2011 | Source: CNBC-TV18
Sun Pharma has target of Rs 553, says Sudarshan Sukhani, s2analytics.com....
11.26 am | 28 Nov 2011 | Source: CNBC-TV18
Ajanta Pharma has target of Rs 425 in the next 12 months, says PN Vijay, Portfolio Manager....
7.36 pm | 25 Nov 2011 | Source: CNBC-TV18
Sudarshan Sukhani, technicaltrends.com is of the view that one can buy Dr Reddys Laboratories, Cipla on decline....
9.11 am | 15 Nov 2011 | Source: CNBC-TV18
Buy Dr Reddys Laboratories, says Sudarshan Sukhani of technicaltrends.com. ...
9.24 am | 02 Nov 2011 | Source: CNBC-TV18
On CNBC-TV18's new show Super Six, market gurus Hemen Kapadia, CEO of chartpundit.com, Rajesh Jain, EVP Retail Research, Religare Sec and Sanjeev Agar...
2.49 pm | 25 Oct 2011 | Source: CNBC-Awaaz
Rakesh Bansal for rajeshbansal.com is positive on Bajaj Auto, Bharti Airtel, Dr Reddys and HUL....
1.19 pm | 06 Sep 2011 | Source: CNBC-Awaaz
Shardul Kulkarni of Angel Broking feels that one should exit Dr Reddys. ...
2.00 pm | 02 Sep 2011 | Source: CNBC-Awaaz
Dr Reddys is looking good, says Salil Sharma of Kapoor Sharma and Company. ...
8.59 am | 22 Aug 2011 | Source: CNBC-TV18
On CNBC-TV18's new show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment, Abhijit Paul of Brics Securities and Rajesh...
8.48 am | 22 Aug 2011 | Source: CNBC-TV18
CNBC-TV18 brings you a brand new week of Bull's Eye. It's the popular game show where market experts come together to dish out trading strategies for ...
8.32 am | 29 Jul 2011 | Source: CNBC-TV18
On CNBC-TV18's in Super Six show, market gurus Arunesh Madan, Founder and Director of Augment Investment Pvt ltd, Abhijit Paul, Technical Analyst of B...
4.19 pm | 21 Jul 2011 | Source: CNBC-Awaaz
Gaurav Jain of Hem Securities advises to invest in Dr Reddys. ...
6.51 pm | 13 Jul 2011 | Source: CNBC-TV18
Rajesh Jain, Independent Market Strategist feels that, Dr Reddy’s will once again get back to the three most Indian pharma preferred stocks....